The S&P 500, the Dow Jones, and the NASDAQ all moved between 0.8% and 1% lower by mid-afternoon. Palantir (PLTR) stock ...

New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Merck & Co. is strutting into the spotlight as a top contender among the most profitable cheap stocks, thanks to its robust ...

In the vehicles’ strongest showing since early 2022, there were eight new SPACs from April 28 through May 5. Of those eight, ...

Merck broke ground on a $1B, 470K SF biotech facility last month at the Chestnut Run Innovation & Science Park in Wilmington, ...

During a recent sit-down interview with The News Journal, Gov. Matt Meyer discussed changes to how schools are funded in ...

Merck filed for approval of gefapixant in March 2021 on the strength of a pair of phase 3 trials – COUGH-1 and COUGH-2 – which found that the drug reduced 24-hour cough frequency by 18% and 15 ...

Tuesday’s US economic news was also negative for stocks after the March US trade deficit was reported at a record -$140.5 billion, wider than expectations of -$137.2 billion and a negative factor for ...

Furthermore, expanding research into chondroitin’s therapeutic benefits in treating osteoarthritis and other joint-related diseases is likely to spur demand during the forecast period. The chondroitin ...

Funding supports neuroelectronic technologies as part of national strategy to boost Spain's microelectronics and semiconductor industry INBRAIN Neuroelectronics, a clinical-stage neurotechnology ...